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Abstract
Cancer is the second cause of death worldwide, whose treatment often involves
chemotherapy. In a conventional therapy, drug is transported (and usually absorbed)
across biological membranes through diffusion and systemic transport. The pathway
that medicine must travel before reaching the desired location, can bring adverse or
unwanted effects, which are mainly the result of: low bioavailability, low solubility and
toxicity. To avoiding risks, nanoparticles coated with the drug could be used as a
therapeutic substance to selectively reach an area of interest to act without affecting
non-target cells, organs, or tissues (drug delivery). Here, the goal is to enhance the
concentration of the chemotherapeutic drug in the disease parts of the body. Among
all nanostructured systems, ferrites attract worldwide attention in drug delivery appli-
cations. It is due to their versatile magnetic and physicochemical properties. Here, it is
reviewed and analyzed recent advances in synthesis, morphology, size, magnetic
properties, functionalization with a focus in drug delivery applications of nanoferrites.
Keywords: Ferrites, Nanostructures, Functionalization, Drug-loading, Drug
delivery, Cancer
1. Introduction
Cancer is a disease originating from unregulated cell growth. Those cells can
spread throughout the body, causing erroneous behaviors in organs or tissues [1].
Cancer is one of the principal problems in public health and currently is the second
leading cause of death worldwide. According to the American Joint Committee on
Cancer (AJCC) and the International Union for Cancer Control (UICC), there are
many types of cancer treatments. Treatment or therapy depends on the cancer, as
well as its stage of progress. Most individuals with cancer receive a combination of
treatments, such as surgery with chemotherapy and/or radiation therapy [2]. Che-
motherapy is crucial in the prevention of tumor recurrence and progression. Some
patients have been treated with chemotherapeutic agents (e.g., Doxorubicin, Cyclo-
dextrin, Cisplatin, Taxanes, Gemcitabine, among others) for long-term survival.
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Despite recent advances in treatments for various types of cancer, the recurrence rate
and severe side effects still are a problem. To improve the life quality of cancer
patients, more efficient and accurate targeting treatment is an urgent need.
A nanotechnology-based drug delivery system may provide a feasible means to
solve the previous challenges. This kind of technology can be a formulation or
device that enables a therapeutic substance to selectively reach an area of interest to
act without affecting non-target cells, organs, or tissues [3]. One of the most
studied, promising, and simplest ways to transport pharmaceutical compounds in
the body is using nano entities as delivery vehicles [4]. Moreover, some
nanoparticulated systems exhibit sensitivity to external stimuli, such as visible light,
near-infrared light, ultrasound, AC or DC magnetic fields, among others. These
stimuli could be made use as a tool to flexible control of dose magnitude and timing
from the responsiveness (triggered remotely) [5].
Specifically, nanoferrites have been attracted worldwide scientific community
attention for applications against cancer due to [6]:
• Their great potential for hyperthermia treatments.
• The possibility to guide nanoparticles to specific regions using an external
magnetic field.
• The chance to remotely activate the drug release in a controlled way
(alternating magnetic fields).
Ferrites are compounds derived from iron oxides, whose composition allows
tuning the magnetic properties. According to the magnetic atoms disposition and its
chemical environment, material can manifest hard of soft magnetic properties.
Nanostructure ferrites have received the most attention for drug delivery applica-
tions due to their versatile magnetic and chemical properties [7].
Previous reports have pay attention to the use of nanoferrites in biomedical
applications for:
• Improving magnetic resonance imaging sensitivity [8].
• Effective targeted treatment of lung cancer [7].
• Magnetite nanoparticles as an advanced platform for cancer theranostics [9].
• Hydrogel beads-based nanoferrites in novel drug delivery platforms [10].
• Magnetic and superparamagnetic ferrites for cancer therapy applications [11].
• Iron oxide and substitute ferrite nanoparticles in drug delivery [12].
• The toxicity of spinel ferrite nanoparticles [13].
• Biosensing platform on ferrite nanoparticles [14].
Thus, the chapter aims to correlate the morphology, size, ferrite type, magnetic
properties, functionalization, and pharmacokinetics. These correlations allow
obtaining a perspective to the physical targeting precision for cancer drug delivery
applications. Furthermore, we also discussed the current challenges and future
perspectives of nanoferrites in the field of oncology.
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2. Size, morphology, and magnetic properties of nanoferrites for drug
delivery in cancer
The size, morphology, and magnetic properties of nanoparticles in drug delivery
applications, have been identified as keys parameters in the literature [1, 2]. The
easy way to tune these properties is from the synthetic routes [15]. The growth
mechanism involved in the final morphology and structure is not completely clear.
The conditions synthesis and their correlation with the physicochemical properties
have been discussed in the literature [16]. Here, we focus on the recent advances in
morphology, size, magnetic properties, and their relationship with the synthetic
routes of nanoferrites used in drug delivery for cancer. Table A1 shows a summary
of these properties recently reported in the literature. For there, it is clear that the
synthetic routes more employed for nanoferrites synthesis are:
• Chemical coprecipitation: it is a straightforward and inexpensive method. In this
case, the precursor salts solutions containing the cationic metals are mix into an
alkaline medium in a stoichiometric proportion.
• Hydrothermal: here, the chemical reactions take place in aqueous solutions at
pressure and temperature higher than the room conditions.
• Sol–gel: the chemical reactions of hydrolysis and condensation are carried out
of precursors in solution.
Figure 1.
Transmission Electron microscopy (TEM) images for a) calcium ferrite nanoparticles with a size of 5 nm,
reproduced from Ref. [17] with permission of the editors, b) magnetite hollow spheres of diameter 350 nm,
reproduced from Ref. [65] with permission of the editors, c) magnetite nanorods, reproduced from Ref. [48]
with permission of the editors, and d) magnetite hexagonal nanoparticles, reproduced from Ref. [56] with
permission of the editors. Copyright 2019 MDPI, 2016 Nature, 2020 Elsevier, and 2021 the Royal Society of
Chemistry.
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• Solvothermal: it is like the hydrothermal technique. The difference is the use of
nonaqueous solutions.
• Less popular synthesis techniques for nanoferrites obtention are thermal
decomposition, sonochemical, thermal treatment, and thermolysis.
Tripathy et al. [14] reported a comparison among the different techniques for
ferrite nanoparticles obtention.
Based on some scientific reports, nanoferrites used in cancer drug delivery
applications range from 5.2 nm to 300 nm (Table A1). Calcium ferrite (CaFe2O4)
obtained by coprecipitation is the smallest nanostructure system. Magnetite
(Fe3O4) fabricate from the solvothermal method is the larger one (Figure 1). How-
ever, particles larger than 200 nm segregate by mechanical filtering and eventually
get removed by phagocytic cells. Nanoparticles with sizes smaller than 10 nm lead
to renal filtration and accumulation into the fenestration of the kidneys’ glomerular
endothelium. Therefore, the most effective drug delivery agents possess sizes rang-
ing between 10 and 100 nm [68]. However, Sivaraj et al. [69] suggest that the
nuclear membrane pores allow entry of nanoparticles with a size below 9 nm.
Nanoparticles penetration into the cells may be maximized by surface functiona-
lization with small molecules (e.g. folate, proteins, peptides, antibodies, and
aptamers). This penetration induces receptor-mediated endocytosis, caveolae-
mediated endocytosis, lipid raft mediated endocytosis, and/or micropinocytosis.
After endocytosis in cancer therapy, nanomaterial releases maximum drug to
inhibit the DNA/RNA synthesis and mitochondria damage.
The most common ferrite nanoparticles use for cancer drug delivery systems
ranging from 20 nm to 30 nm (Table A1). Moreover, the most popular morphology
FT Method S MS HC MR Reference
Fe3O4 Coprecipitation 11 59 0 — [20]
CoFe2O4 Thermal decomposition 13 70.7 — 30.2 [22]
MnFe2O4 Sonochemical 13 34.9 0 0 [23]
Mn-Zn (Fe2O4) Coprecipitation 15 56.0 0 0 [25]
NiFe2O4 Solvothermal 17 70 0 0 [29]
Fe3O4 Thermal treatment 23 7.1 143.8 2.2 [32]
Fe3O4 Coprecipitation 30 47.6 0 3.8 [39]
Fe3O4 Coprecipitation 35 36.3 0 — [40]
Fe3O4 Coprecipitation 40 1.57 69.1 0.15 [41]
CoFe2O4 Coprecipitation 43 36.02 0 0 [42]
GdFe2O4 Coprecipitation 90 47 0 0 [57]
CoFe2O4 Solvothermal 104 51.8 0 0 [59]
CaFe2O4 Sol–gel 112 14.9 — 0.38 [61]
MnFe2O4 Coprecipitation 140 56.1 42.6 5.2 [62]
CoFe2O4 Thermolysis 200 51.1 0 0 [64]
CoFe2O4 Coprecipitation 250 40 1.7 — [65]
Table 1.
Summary of spherical nanoparticles ferrite type (FT) obtained by different methods with their sizes (S in nm),
saturation magnetization (MS in emu/g), coercivity (HC in Oe), and remanence (MR in emu/g), reported in
the literature. All the magnetic properties were reported at room temperature.
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obtained from the synthetic routes is spherical particles (Table 1). Nanorods and
particles with hexagonal shapes are the less common nanostructures used for drug
delivery in cancer applications (Figure 1).
A complete understanding of magnetic properties is essential for a proper
implementation of nanoferrites in drug delivery applications [6]. The saturation
magnetization (Ms), coercive force (HC), and remanence (MR) are the most popular
magnetic parameters reported for nanoferrites to cancer drug delivery applications
(Table A1). Nanoferrites with the highest magnetic response (Ms) are cobalt ferrite
(CoFe2O4) with a size of 15 nm obtained by sonochemical technique [28]. The
smallest saturation magnetization was reported to zinc ferrite (ZnFe2O4)
nanostructures (75 nm), which were synthesized by the sol–gel method [53].
Usually, nanoferrites used in cancer drug delivery applications show superpara-
magnetic behavior. Superparamagnetic nanoparticles evidence zero coercivity and
remanence at temperatures above the blocking one (Table 1). In other cases, ferrite
nanostructures with coercivity as high as 3409 Oe are used in cancer drug delivery
applications (CoFe2O4 nanofibers with a diameter of 50 nm [45]. Moreover, cobalt
ferrite nanoparticles show the highest magnetic remanence of 30.2 emu/gwith a size
of 30 nm obtained by thermal decomposition (Table 1).
3. Nanoferrites functionalized and functional groups for drug delivery
in cancer
Non-functionalized nanoferrites (non-coating material on their surface) seems
to be not optimal for drug delivery application. Surface energy minimization pro-
cesses can promote agglomeration, percolation as well as other unwanted effects.
Some of the most common problems whit this kind of nanosystems are [12]:
1.Agglomeration due to the attractive forces leading to non-stability of the
nanoparticle dispersion.
2.Toxicity represents a problem in bare nanoferrites when they use without
functionalization.
3.Bare nanoparticles do not have a functional group on their surface. This makes
it hard to link drugs molecules.
To deal with these problems, nanoparticles have been coating with organic or
inorganic molecules (functionalization). The surface engineering of ferrites could
be accomplished during nanoparticle synthesis (in-situ) or after this (ex-situ). A
detailed review of the coating and functionalization strategies was reported for
nanoparticles in drug delivery applications by Pinelli et al. [70]. The surface
functionalization procedure and choice of appropriate solvent are crucial factors
for obtaining nanoferrites. Here, the repulsive interactions among nanoparticles
prevent agglomerations [71]. Moreover, functionalization promotes several advan-
tages such as stable dispersions, biocompatibility, biodegradability, and reduced
toxicity. Usually, functionalized nanoparticles loaded with drugs adopt covalent/
noncovalent interaction methods. Conjugation of a drug to a carrier by non-
biodegradable linkages results in: changing the drug chemical units, reducing drug
efficacy, and displaying relevant side effects. The drug remains unharmed by using
physical adsorption for drug conjugation, and no changes occur in the chemical
units and the controlled drug release behavior. In this case, the idea deals with
functionalized nanoparticles that have an opposite electrical charge to the cancer
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drug to promote the electrostatic interaction [42]. Moreover, surface functionality
gives significant strength to bind and adsorb cancer drugs using specific functional
groups. The characterization techniques for studying the functional groups attached
to nanoparticles for drug delivery applications have been reported previously [12].
Some examples of functional groups commonly used to functionalized
nanoferrites in drug delivery applications are:
• The carboxyl functional group of the meso, 2–3-dimercaptosuccinic acid
(DMSA), was used to functionalize cobalt ferrite nanoparticles [22].
• Magnetite nanoparticles functionalized with mesoporous silica (SiO2) [58].
• Zinc ferrite nanoparticles coated with hydroxyapatite as an intermediate of the
cancer drug [72].
• The carboxyl functional groups of citrate molecules use to functionalize
manganese ferrite nanorods [24].
• Calcium ferrite functionalized with biomolecules (casein). The hybrid
molecule combines the merits of both inorganic and organic counterparts [61].
The functionalization can allows high drug encapsulation, stabilizes the
nanocarrier, and reaches the cancer site-specific. Furthermore, the coating uses to
reach the target cells without getting removed by the reticuloendothelial system of the
body and to have a capable surface for keeping the drug unharmed until reaching the
location of interest. The performance enhancement achieves through functionalization
with suitable ligands that will bind to the aimed receptors of pathological tissues. The
size of the nanocarrier has paramount importance for rendering it absorbable by
tumor tissues [68]. The inclusion of active targeting functionalities results in drug
accumulation within tumors, tumor cells, or immune cells and allows for reduced
dosages due to specificity. Functionalized ferrite nanoparticles have been used for: a)
imitate ligand binding to receptors, b) for initiation of cellular signaling, c) for
increased stimulation of immune cells to better infiltrate and extinguish immunosup-
pressive tumors [73]. Commonly, the pH of cancer cells (tumor) is acidic ranging
between 4 and 5. It is due to the presence of lactic acid, which starts due to inefficient
consumption of glucose [74]. On the other hand, the pH in an extracellular matrix or
bloodstream is natural (pH = 7) [75]. This difference in pH offers to fabricate
functionalized nanoparticles as a pH-sensitive trigger for drug delivery applications.
The most popular drugs for cancer delivery applications, using ferrites as
nanocarriers are: Doxorubicin [58], 5-Fluorouracil [21], Docetaxel [76], Hesperidin
and Eugenol [60], Curcumin [77], Tamoxifen [55], Cisplatin [78], Nilotinib [79],
Camptothecin [38], and Telmisartan [20]. Hydrophobicity of the orally adminis-
tered drugs for cancer treatments has low systemic bioavailability [80]. It produces
low water solubility and can cause serious adverse effects [62].
Among functionalized nanoferrites investigated to load cancer drugs, one can find:
1.Zinc ferrite functionalized with Polyethylene Glycol (PEG) and chitosan
loaded with Curcumin [80]. Chitosan takes cationic amine functional groups,
at low pH, which would involve an ionic gelation process with polyanions to
form nanoparticles. It is used as an effective drug carrier, where the reactive
amine groups on the chitosan side chain are used for functional group
modifications. The hydrophobically modified chitosan improves the
encapsulation efficiency of the carrier towards the hydrophobic drugs [34].
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2.Cobalt ferrite nanoparticles functionalized with DMSA used the amine
functional group of Doxorubicin molecules. Here, it is attached through
electrostatic interaction and/or hydrogen bonding interactions with the
carboxylic functional group of the DMSA [22].
3.Magnetite nanoparticles functionalized with mesoporous silica used the amine
group of Doxorubicin to attach [58].
4.Zinc ferrite nanoparticles functionalized with hydroxyapatite had covalent
bonds with the zoledronic acid drug. Amino or hydroxyl functional groups
presented in hydroxyapatite are a strong chemical bond with the mineral
material of bone phases [54].
5.Magnetite nanoparticles functionalized with gelatin using the functional
groups -NH3+-. It produces by partial hydrolysis of collagen to interact with
Doxorubicin [81].
6.Calcium ferrite nanoparticles functionalized with biomolecules (casein), which
allows the conjugation of targeting ligands with functional groups. Actively bind
with specific receptors that may be overexpressed on tumor cells, allowing
improved biodistribution and delivery of the drugs at the cancer site [61].
7.Manganese ferrite nanorods functionalized with citrate molecules to
electrostatically attach Doxorubicin [24].
Proteins are promising carriers for drug delivery applications. The main advan-
tages are the abundance of active sites, improved biocompatibility, easy availability,
and pH-dependent swelling behavior. The last one allows the programmed release
of the cytotoxic agent in response to the acidic cancer microenvironment [82].
DFT calculations demonstrated Cisplatin on graphene oxide can be adsorbed by
the functionalized nanoferrites. Here, hydrogen bonds forming with hydroxyl and
epoxy functional groups. It involves the formation of the amide bond between
Cisplatin and the COOH functional group of graphene oxide. In the case of glutar-
aldehyde, the functional group is CHO, which formed the amide bond between
Cisplatin and the CHO functional group [18].
4. Drugs loaded on functionalized nanoferrites for cancer treatments
Drug-loading of nanoparticles plays an essential role in drug delivery systems.
There are several ways through which the drug can load with the functionalized
nanoparticle:
• Encapsulation. It can entrap inside the nanoparticle.
• Functionalization. It can coat the surface of the nanoparticle.
• Chemically linked. It can be bond with the functionalized particle itself.
The second key point in functionalized nanoparticles design is the necessity to
provide the nanoparticles with specific properties. The interaction with the external
environment in the human body increases the targeting action towards determined
sites [70].
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